Stocks · Health care · Pharmaceutical Preparations

CYPHERPUNK TECHNOLOGIES INC.

CYPH Clue Score23
United States Fiscal year ends December CIK 0001509745 Results filed 12 Aug 2026

What the insiders did No buying or selling

By person

18 insiders · 2 transactions
0.5×

Douglas E. Onsi holds only 0.5 times base salary in stock. $418.88K of shares against $708.75K in salary for 2025.

Salary from the company's own proxy. The shares are what Douglas E. Onsi last reported holding, valued at $3.92, the price Common Stock was last bought or sold at on the open market here, on 25 Sep 2026.

Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Winklevoss Capital Fund, LLC entity
10% owner
—
—
—
54,648,027
$214.22M
+64.9%
William Patrick McEvoy III
Chief Investment Officer
—
—
—
54,648,027
$214.22M
+64.9%
Augustine Lawlor
Chief Operating Officer
—
—
—
698,245
$2.74M
+2.5%
James H Cavanaugh
Director
—
—
—
168,963
$662.33K
−35.5%
Joseph Loscalzo
Director
—
—
—
168,750
$661.50K
—
Christian M Richard
Director
—
—
—
168,750
$661.50K
—
William Li
Director
—
—
—
168,750
$661.50K
—
Nissim Mashiach
Director
—
—
—
168,750
$661.50K
—
Richard Schilsky
Director
—
—
—
168,750
$661.50K
—
Thomas John Dietz
Director
—
—
—
132,500
$519.40K
—
Christopher Mirabelli
Director
—
—
—
130,376
$511.07K
−80.9%
Patricia A. Martin
Director
—
—
—
118,750
$465.50K
—
Douglas E Onsi
CEO,CFO,Pres.,GC,Treas.&Sec.
—
—
—
106,858
$418.88K
−85.8%
Cynthia Sirard
Chief Medical Officer
—
—
—
27,500
$107.80K
+450.0%
John Mark O'Mahony
Chief Manufacturing Officer
—
—
—
27,500
$107.80K
+450.0%
Jason Baum
Chief Scientific Officer
—
—
—
15,896
$62.31K
—
Christine Granfield
VP, Head of Reg Affairs/Qual
—
—
—
15,896
$62.31K
—
Khing Djien Oei
Director
—
—
—
0
$0.00
—

No percentages here. This company's share count has moved by a factor of 2.6 over the window, from 41,257,602 to 107,764,382 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.